Agoraphobia Test
How the Scales are Structured
Who Usually Takes This Test?
See How You Compare
Below is a preview of how scores are typically distributed across each scale.
Once you complete the test, your result will appear on the scale so you can see how you compare.
Once you complete the test, your result will appear on the scale so you can see how you compare.
Once you complete the test, your result will appear on the scale so you can see how you compare.
Once you complete the test, your result will appear on the scale so you can see how you compare.
Once you complete the test, your result will appear on the scale so you can see how you compare.
Once you complete the test, your result will appear on the scale so you can see how you compare.
Frequently Asked Questions
/https://freudly.ai/media/tests/1785/image/1764547729_day_image_20251201_000848.png)
This measure is designed to quantify the severity of symptoms associated with agoraphobia, with or without accompanying panic attacks. Developed by Borwin Bandelow, the Agoraphobia Test uses the Panic and Agoraphobia Scale (PAS) to assess core domains including panic symptom frequency and intensity, anticipatory anxiety, avoidance behavior, and functional impairment. It includes 13 items and typically takes about 3 minutes to complete.
Why Take an Agoraphobia Test
Agoraphobia often starts small — avoiding one specific place after an uncomfortable experience there — and then quietly expands. Over time, more situations get added to the list of places that feel unsafe: crowded stores, public transportation, being far from home, or anywhere that feels hard to leave quickly if something goes wrong. Because this expansion happens gradually, it's easy to underestimate how much daily life has actually been reshaped around avoidance until it's mapped out clearly.
A structured test for agoraphobia captures this pattern with precision. Rather than describing avoidance in general terms, the PAS asks about specific domains — how intense panic symptoms are, how much anticipatory dread builds up before facing a feared situation, and how much daily activities have been scaled back as a result. This specificity is directly useful for treatment, since agoraphobia responds well to structured approaches like exposure-based CBT, and tracking these specific domains shows clearly whether avoidance is actually decreasing.
This agoraphobia quiz is especially useful for people who experience sudden surges of fear and physical symptoms and want to gauge how severe and impairing their panic episodes are, and for those already in treatment who want a quick, repeatable way to monitor change.
What the Assessment Measures
The PAS assesses agoraphobia and panic severity across several core domains:
- Panic symptom frequency and intensity — how often panic attacks occur and how intense the physical and emotional symptoms feel
- Anticipatory anxiety — dread or worry that builds up in advance of entering a feared situation
- Agoraphobic avoidance — the extent to which places or situations are avoided due to fear of being unable to escape or get help
- Functional impairment — how much these symptoms limit daily activities, work, and social life
Scores support initial clinical characterization and provide a structured way to monitor change over time with treatment. Higher scores indicate more severe panic and agoraphobia-related distress and greater activity limitation.
Who This Assessment Is For
This Agoraphobia Test is appropriate for anyone who experiences sudden surges of fear and physical symptoms and wants to gauge how severe and impairing their panic episodes are, and for those who fear being unable to escape or get help in open or crowded settings and want to measure their agoraphobic anxiety and avoidance. It is also used by individuals already in psychotherapy or on medication to track symptom changes and treatment response periodically with a clinician.
Clinical Validity and Use in Practice
The PAS was developed by Bandelow and is compatible with DSM-IV and ICD-10 classifications, widely used internationally to monitor treatment efficacy for panic disorder and agoraphobia. Results from this agoraphobia quiz support initial clinical characterization and treatment monitoring but are not a standalone diagnostic instrument. Where scores indicate moderate or high severity, consultation with a mental health professional experienced in treating panic and agoraphobia, such as through exposure-based CBT, is recommended.